Researchers report progress on a broadly protective influenza vaccine candidate

Researchers have reported early-phase trial results for an influenza vaccine candidate designed to protect against multiple circulating strains, describing a durable immune response in participants over six months.

Editorial note: early-phase results measure immune response, not clinical protection.

How the candidate works

The approach targets conserved regions of the virus that mutate more slowly than the surface proteins used by seasonal vaccines.

What comes next

Investigators said larger trials are required to establish whether the immune response translates into reduced infection or severe illness.